The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer

This publication has 51 references indexed in Scilit:

• Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion
  Biochemical and Biophysical Research Communications, 2010
• Molecular characterization of ovarian cancer by gene-expression profiling
  Gynecologic Oncology, 2010
• Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis
  Journal of Experimental & Clinical Cancer Research, 2010
• Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis
  Clinical & Experimental Metastasis, 2009
• CXCL12 (SDF-1α) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells
  Journal of Experimental Medicine, 2008
• Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo
  Journal of Cancer Research and Clinical Oncology, 2008
• Histologic Subtypes of Ovarian Carcinoma
  International Journal of Gynecological Pathology, 2008
• CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
  Biochemical and Biophysical Research Communications, 2007
• CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins
  Neoplasia, 2006
• Up-regulation of CXCR4 Expression in PC-3 Cells by Stromal-Derived Factor-1α (CXCL12) Increases Endothelial Adhesion and Transendothelial Migration: Role of MEK/ERK Signaling Pathway–Dependent NF-κB Activation
  Cancer Research, 2005